Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 19, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Normal tissue protection for improving radiotherapy: Where are the Gaps?

Pataje G S Prasanna1, Helen B Stone, Rosemary S Wong

  • 1Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.

Translational Cancer Research
|August 7, 2012
PubMed
Summary

Radiation therapy can control tumors, but normal tissue injury remains a challenge. New research explores radioprotectors and mitigators to improve cancer treatment outcomes by protecting healthy tissues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth.

Cancer cell·2026
Same author

Best practices and novel approaches for the preclinical development of drug-radiotherapy combinations for cancer treatment.

The Lancet. Oncology·2024
Same author

Harnessing Senescence for Antitumor Immunity to Advance Cancer Treatment.

Radiation research·2024
Same author

The United States Department of Energy and National Institutes of Health Collaboration: Medical Care Advances by Discovery in Radiation Detection.

Medical physics·2024
Same author

Older adults with cancer and common comorbidities-challenges and opportunities in improving their cancer treatment outcomes.

Journal of the National Cancer Institute·2024
Same author

Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities.

The Lancet. Oncology·2024

Area of Science:

  • Oncology
  • Radiation Biology
  • Pharmacology

Background:

  • Radiation therapy is a cornerstone of cancer treatment, but normal tissue toxicity limits its efficacy.
  • Technological advancements improve radiation dose conformity, yet normal tissues are still exposed.
  • Understanding normal tissue injury mechanisms and developing radioprotectors are crucial for enhancing radiation therapy outcomes.

Purpose of the Study:

  • To review current knowledge on normal tissue injury from radiation therapy.
  • To explore the development and application of novel radioprotectors and mitigators.
  • To discuss strategies for improving radiation therapy by minimizing side effects and enhancing tumor control.

Main Methods:

  • Review of recent scientific literature on radiation biology, normal tissue injury, and radioprotective agents.

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Related Experiment Videos

Last Updated: May 19, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

  • Analysis of mechanisms of cellular damage, repair, and response to radiation.
  • Discussion of drug development concepts for radiation therapy.

    • Main Results:

    • Normal tissue injury is a significant limitation in radiation therapy, varying by organ and radiation dose.
    • Emerging research focuses on biomarkers and countermeasures for normal tissue protection.
    • Radioprotectors and mitigators show promise but require careful consideration of their impact on tumor response.

    Conclusions:

    • Developing effective radioprotectors and mitigators necessitates a multi-faceted approach, considering site-specific needs.
    • Advances in understanding tissue biology and injury mechanisms are vital for progress.
    • Future strategies should integrate normal tissue protection into clinical cancer care to improve patient outcomes.